Gotham Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-67,513
Closed -$4.78M 1174
2016
Q4
$4.78M Sell
67,513
-9,654
-13% -$719K 0.06% 388
2016
Q3
$6.1M Buy
+77,167
New +$6.58M 0.08% 326
2015
Q4
Sell
-687,078
Closed -$48.4M 1069
2015
Q3
$48.4M Buy
687,078
+488,149
+245% +$40.2M 0.47% 54
2015
Q2
$17.9M Buy
198,929
+190,264
+2,196% +$18.3M 0.15% 219
2015
Q1
$871K Buy
+8,665
New +$874K 0.01% 618
2014
Q3
Sell
-5,758
Closed -$536K 1118
2014
Q2
$536K Buy
+5,758
New +$503K 0.01% 771
2014
Q1
Sell
-9,546
Closed -$800K 1137
2013
Q4
$800K Buy
+9,546
New +$777K 0.02% 670

Other funds holding MJN

Gotham Asset Management's MJN Position: Q1 2017 in Review

Gotham Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 67,513 shares — an estimated $4.78M sold.

Gotham Asset Management first reported a position in MJN in Q4 2013 and held it in 7 quarters. The position peaked at $48.4M in Q3 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Gotham Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Gotham Asset Management sold 67,513 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $4.78M.
  • Gotham Asset Management first reported a position in Mead Johnson Nutrition Company in Q4 2013 and held it in 7 quarters.
  • Gotham Asset Management's Mead Johnson Nutrition Company position peaked at $48.4M in Q3 2015.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Gotham Asset Management's 13F filing for Q1 2017, filed 15 May 2017.